BioCentury | May 1, 2000
Company News

Nymox management update

...Neurological Hired: Allan Reimer as VP of technology acquisition and development, formerly an analyst at Credifinance...
BioCentury | Feb 18, 1997
Company News

Receptagen, InterUnion Financial Corp. cancer, infectious diseases/aids, supply/service news

...receive a yet-to-be determined number of units of RCEPF, plus a fee paid to IUFC's Credifinance...
...and patent rights. In the third stage, Credifinance Securities Ltd., a wholly owned subsidiary of Credifinance...
BioCentury | Jan 3, 1995
Analyst Picks & Changes

Analyst picks & changes

...Hyal Pharmaceutical Corp. (HYALF) Credifinance Securities analyst Bin Huang maintained a "buy" on the Toronto company...
BioCentury | Oct 10, 1994
Analyst Picks & Changes

Analyst picks & changes

...Hyal Pharmaceutical Corp. (HYALF) Bin Huang of Credifinance Securities reiterated a "buy" following the Toronto company's...
Items per page:
1 - 4 of 4
BioCentury | May 1, 2000
Company News

Nymox management update

...Neurological Hired: Allan Reimer as VP of technology acquisition and development, formerly an analyst at Credifinance...
BioCentury | Feb 18, 1997
Company News

Receptagen, InterUnion Financial Corp. cancer, infectious diseases/aids, supply/service news

...receive a yet-to-be determined number of units of RCEPF, plus a fee paid to IUFC's Credifinance...
...and patent rights. In the third stage, Credifinance Securities Ltd., a wholly owned subsidiary of Credifinance...
BioCentury | Jan 3, 1995
Analyst Picks & Changes

Analyst picks & changes

...Hyal Pharmaceutical Corp. (HYALF) Credifinance Securities analyst Bin Huang maintained a "buy" on the Toronto company...
BioCentury | Oct 10, 1994
Analyst Picks & Changes

Analyst picks & changes

...Hyal Pharmaceutical Corp. (HYALF) Bin Huang of Credifinance Securities reiterated a "buy" following the Toronto company's...
Items per page:
1 - 4 of 4